Gut microbiome modulates efficacy of immune checkpoint inhibitors
Abstract Immune checkpoint inhibitors (ICIs) therapy is a novel strategy for cancer treatments in recent years. However, it was observed that most patients treated with ICIs could not get benefit from the therapy, which led to the limitation of clinical application. Motivated by potent and durable e...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2018-03-01
|
| Reeks: | Journal of Hematology & Oncology |
| Onderwerpen: | |
| Online toegang: | http://link.springer.com/article/10.1186/s13045-018-0592-6 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|